Immunometabolism adaptation in leukemia/lymphoma and new therapeutic opportunities

Project Details

AcronymNextimmune-2 (Alice Verdier)
StatusActive
Effective start/end date1/10/2330/09/27

Funding

  • FNR - Fonds National de la Recherche: €186,000.00